Scarring Alopecia Associated With Use of the Epidermal Growth Factor Receptor Inhibitor Gefitinib

被引：24
|
作者：
Donovan, Jeffrey C.
Ghazarian, Danny M.
Shaw, James C.
机构：
来源：
ARCHIVES OF DERMATOLOGY | 2008年 / 144卷 / 11期
关键词：
D O I：
10.1001/archderm.144.11.1524
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1524 / 1525
页数：2
相关论文
共 50 条
  • [11] Aberrant Activation of Epidermal Growth Factor Receptor in MPN May Respond to the Kinase Inhibitor Gefitinib
    Casolari, Debora A.
    Iarossi, Diana G.
    Butcher, Carolyn M.
    Bray, Sarah C.
    Parker, Wendy T.
    Hahn, Chris N.
    Branford, Susan
    Bardy, Peter
    Lewis, Ian D.
    Scott, Hamish S.
    Lane, Steven W.
    Ross, David M.
    D'Andrea, Richard J.
    BLOOD, 2014, 124 (21)
  • [12] Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib
    Govindan, R
    Behnken, D
    Read, W
    McLeod, H
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1330 - 1331
  • [13] Severe Refractory Scarring Alopecia Associated With Combinational Use of Ficlatuzumab (AV-299) and Gefitinib
    Shih, Yi-Hsien
    Chen, Pin-Chun
    Chu, Chia-Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : E335 - E337
  • [14] Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
    Eames, Tatiana
    Kroth, Julia
    Flaig, Michael J.
    Ruzicka, Thomas
    Wollenberg, Andreas
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (02) : 202 - 203
  • [15] Thrombotic microangiopathy associated with cetuximab, an epidermal growth factor receptor inhibitor
    Koizumi, Mitsuteru
    Takahashi, Masahiro
    Murata, Maki
    Kikuchi, Yuko
    Seta, Koichi
    Yahata, Kensei
    CLINICAL NEPHROLOGY, 2017, 87 (01) : 51 - 54
  • [16] Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
    Piper-Vallillo, Andrew J.
    Costa, Daniel B.
    Sabe, Marwa A.
    Asnani, Aarti
    JACC: CARDIOONCOLOGY, 2020, 2 (01): : 119 - 122
  • [17] Nail toxicity associated with epidermal growth factor receptor inhibitor therapy
    Fox, Lindy P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (03) : 460 - 465
  • [18] Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor
    Dainichi, T
    Tanaka, M
    Tsuruta, N
    Furue, M
    Noda, K
    DERMATOLOGY, 2003, 207 (03) : 324 - 325
  • [19] Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients
    Paul, Tanusree
    Schumann, Christian
    Ruediger, Stefan
    Boeck, Stefan
    Heinemann, Volker
    Kaechele, Volker
    Steffens, Michael
    Scholl, Catharina
    Hichert, Vivien
    Seufferlein, Thomas
    Stingl, Julia Carolin
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (11) : 1855 - 1863
  • [20] Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man
    McKillop, D
    Hutchison, M
    Partridge, EA
    Bushby, N
    Cooper, CMF
    Clarkson-Jones, JA
    Herron, W
    Swaisland, HC
    XENOBIOTICA, 2004, 34 (10) : 917 - 934
12345